Dennis Langer, Director at MYRIAD GENETICS INC (MYGN), sold 40,738 shares at $39.35 ($1.6M) on 2018-06-07, disclosed to the SEC on 2018-06-08.
Open-market sale of $1.6M MYGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.37 | 3,609 | $142K | 8.9% |
| 2 | $39.37 | 3,609 | $142K | 8.9% |
| 3 | $39.35 | 3,096 | $122K | 7.6% |
| 4 | $39.35 | 3,096 | $122K | 7.6% |
| 5 | $39.35 | 13,664 | $538K | 33.5% |
| 6 | $39.35 | 13,664 |
| $538K |
| 33.5% |
| Total | $39.35 avg | 40,738 | $1.6M | 100% |
| Filing → |
| MYGN | SELL | 2021-08-05 | $1.0M | — | Filing → |
| DRNA | SELL | 2018-08-17 | $613K | — | Filing → |
| MYGN | SELL | 2018-06-05 | $2.0M | — | Filing → |